[1]
Lopes-Pacheco M, Silva PL, Cruz FF, et al. Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies. Front Physiol 2021; 12: 593223.
[http://dx.doi.org/10.3389/fphys.2021.593223] [PMID: 33584343]
[http://dx.doi.org/10.3389/fphys.2021.593223] [PMID: 33584343]
[2]
CDC. Long COVID or Post-COVID Conditions 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html#:~:text=Some%20people%2C%20especially%20those%20who,kidney%2C%20skin%2C%20and%20brain
[3]
Bhalerao A, Raut S, Noorani B, Mancuso S, Cucullo L. Molecular mechanisms of multi-organ failure in COVID-19 and potential of stem cell therapy. Cells 2021; 10(11): 2878.
[http://dx.doi.org/10.3390/cells10112878] [PMID: 34831101]
[http://dx.doi.org/10.3390/cells10112878] [PMID: 34831101]
[4]
Ioganathan S, Kuppusamy M, Wankhar W, et al. Angiotensinconverting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. Respir Physiol Neurobiol 2021; 283: 103548.
[http://dx.doi.org/10.1016/j.resp.2020.103548] [PMID: 32956843]
[http://dx.doi.org/10.1016/j.resp.2020.103548] [PMID: 32956843]
[5]
O’Connor RJ, Preston N, Parkin A, et al. The COVID‐19 yorkshire rehabilitation scale (C19‐YRS): Application and psychometric analysis in a post‐COVID‐19 syndrome cohort. J Med Virol 2022; 94(3): 1027-34.
[http://dx.doi.org/10.1002/jmv.27415] [PMID: 34676578]
[http://dx.doi.org/10.1002/jmv.27415] [PMID: 34676578]
[6]
Umakanth M, Suganthan N. Unusual manifestations of dengue fever: A review on expanded dengue syndrome. Cureus 2020; 12(9): e10678.
[http://dx.doi.org/10.7759/cureus.10678] [PMID: 33133844]
[http://dx.doi.org/10.7759/cureus.10678] [PMID: 33133844]
[7]
Mallhi TH, Yusra HK, Nida T, Raja AA. Expanded Dengue Syndrome. Springer 2021.
[http://dx.doi.org/10.1007/978-981-15-7337-8]
[http://dx.doi.org/10.1007/978-981-15-7337-8]
[8]
Louis TJ, Qasem A, Abdelli LS, Naser SA. Extra-pulmonary complications in SARS-CoV-2 infection: A comprehensive multi organ-system review. Microorganisms 2022; 10(1): 153.
[http://dx.doi.org/10.3390/microorganisms10010153] [PMID: 35056603]
[http://dx.doi.org/10.3390/microorganisms10010153] [PMID: 35056603]
[9]
Ning Q, Wu D, Wang X, et al. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022; 7(1): 57.
[http://dx.doi.org/10.1038/s41392-022-00907-1] [PMID: 35197452]
[http://dx.doi.org/10.1038/s41392-022-00907-1] [PMID: 35197452]
[10]
Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26(7): 1017-32.
[http://dx.doi.org/10.1038/s41591-020-0968-3] [PMID: 32651579]
[http://dx.doi.org/10.1038/s41591-020-0968-3] [PMID: 32651579]
[11]
Zheng KI, Feng G, Liu WY, Targher G, Byrne CD, Zheng MH. Extrapulmonary complications of COVID‐19: A multisystem disease? J Med Virol 2021; 93(1): 323-35.
[http://dx.doi.org/10.1002/jmv.26294] [PMID: 32648973]
[http://dx.doi.org/10.1002/jmv.26294] [PMID: 32648973]
[12]
Mustafa ZU, Maqbool F, Wahid M, et al. Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: A cross-sectional survey from Punjab, Pakistan, and the implications. Rev Soc Bras Med Trop 2023; 56: e0044-2023.
[http://dx.doi.org/10.1590/0037-8682-0044-2023] [PMID: 37283345]
[http://dx.doi.org/10.1590/0037-8682-0044-2023] [PMID: 37283345]
[13]
Mallhi TH, Khan YH, Butt MH, et al. Surveillance of side effects after two doses of COVID-19 vaccines among patients with comorbid conditions: A sub-cohort analysis from Saudi Arabia. Medicina 2022; 58(12): 1799.
[http://dx.doi.org/10.3390/medicina58121799] [PMID: 36557002]
[http://dx.doi.org/10.3390/medicina58121799] [PMID: 36557002]
[14]
Mohamed MS, Mohamed AO, Alenazy R, et al. A first report on side-effects of COVID-19 vaccines among general population in Sudan: A cross-sectional analysis. Vaccines 2023; 11(2): 315.
[http://dx.doi.org/10.3390/vaccines11020315] [PMID: 36851192]
[http://dx.doi.org/10.3390/vaccines11020315] [PMID: 36851192]
[15]
Alzarea AI, Khan YH, Alatawi AD, et al. Surveillance of post-vaccination side effects of COVID-19 vaccines among Saudi population: a real-world estimation of safety profile. Vaccines 2022; 10(6): 924.
[http://dx.doi.org/10.3390/vaccines10060924] [PMID: 35746532]
[http://dx.doi.org/10.3390/vaccines10060924] [PMID: 35746532]
[16]
Amjad Z, Maryam I, Munir M, et al. COVID-19 vaccines status, acceptance and hesitancy among maintenance hemodialysis patients: A cross-sectional study and the implications for Pakistan and beyond. Vaccines 2023; 11(5): 904.
[http://dx.doi.org/10.3390/vaccines11050904] [PMID: 37243008]
[http://dx.doi.org/10.3390/vaccines11050904] [PMID: 37243008]
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Related Books
Anthocyanins: Pharmacology and Nutraceutical Importance
Herbal Medicine for Autoimmune Diseases
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Drug Addiction Mechanisms in the Brain
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Advanced Pharmacy
Article Metrics
9
2
